BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35980134)

  • 41. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.
    Ibrahim F; Al Sabbagh A; Amer A; Soliman DS; Al Sabah H
    Am J Case Rep; 2020 Mar; 21():e921131. PubMed ID: 32150530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.
    Markowitz JT; Mazerolle F; Lovell T; Hess LM; Abada PB; Regnault A; Payakachat N
    J Patient Rep Outcomes; 2024 Jan; 8(1):8. PubMed ID: 38252198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma.
    Tworek JA; Singleton TP; Schnitzer B; Hsi ED; Ross CW
    Am J Clin Pathol; 1998 Nov; 110(5):582-9. PubMed ID: 9802342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?
    Santos FP; O'Brien S
    Cancer J; 2012; 18(5):396-403. PubMed ID: 23006943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma involving bone marrow with an interfollicular pattern.
    Kim YS; Ford RJ; Faber JA; Bell RH; Elenitoba-Johnson KS; Medeiros LJ
    Am J Clin Pathol; 2000 Jul; 114(1):41-6. PubMed ID: 10884798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
    Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
    BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD5+ true SLL/CLL with plasmacytic differentiation and an unusual 1p36 translocation: case report and review of the literature.
    Evans HL; Polski JM; Deshpande V; Dunphy CH
    Leuk Lymphoma; 2000 Nov; 39(5-6):625-32. PubMed ID: 11342346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration.
    Carulli G; Stacchini A; Marini A; Ciriello MM; Zucca A; Cannizzo E; Aliberti S; Demurtas A; Novero D; Calcagno L; Callegari T; Petrini M
    Am J Clin Pathol; 2009 Aug; 132(2):186-90; quiz 306. PubMed ID: 19605812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
    Rawstron AC; Villamor N; Ritgen M; Böttcher S; Ghia P; Zehnder JL; Lozanski G; Colomer D; Moreno C; Geuna M; Evans PA; Natkunam Y; Coutre SE; Avery ED; Rassenti LZ; Kipps TJ; Caligaris-Cappio F; Kneba M; Byrd JC; Hallek MJ; Montserrat E; Hillmen P
    Leukemia; 2007 May; 21(5):956-64. PubMed ID: 17361231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
    Rawstron AC; Fazi C; Agathangelidis A; Villamor N; Letestu R; Nomdedeu J; Palacio C; Stehlikova O; Kreuzer KA; Liptrot S; O'Brien D; de Tute RM; Marinov I; Hauwel M; Spacek M; Dobber J; Kater AP; Gambell P; Soosapilla A; Lozanski G; Brachtl G; Lin K; Boysen J; Hanson C; Jorgensen JL; Stetler-Stevenson M; Yuan C; Broome HE; Rassenti L; Craig F; Delgado J; Moreno C; Bosch F; Egle A; Doubek M; Pospisilova S; Mulligan S; Westerman D; Sanders CM; Emerson R; Robins HS; Kirsch I; Shanafelt T; Pettitt A; Kipps TJ; Wierda WG; Cymbalista F; Hallek M; Hillmen P; Montserrat E; Ghia P
    Leukemia; 2016 Apr; 30(4):929-36. PubMed ID: 26639181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
    Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
    Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.
    Salem DA; Stetler-Stevenson M
    Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
    Pevna M; Doubek M; Coupek P; Stehlikova O; Klabusay M
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [CD43 in B-cell chronic lymphocytic leukemia].
    Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
    Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.
    Chang JC; Harrington AM; Olteanu H; VanTuinen P; Kroft SH
    Ann Diagn Pathol; 2016 Dec; 25():15-19. PubMed ID: 27806839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia.
    Nguyen PC; Nguyen V; Baldwin K; Kankanige Y; Blombery P; Came N; Westerman DA
    Br J Haematol; 2023 Aug; 202(4):760-770. PubMed ID: 37052611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
    Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
    Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.